JPS5262273A - Ppoduction of benzisothiazolone and pharmaceutical composition - Google Patents

Ppoduction of benzisothiazolone and pharmaceutical composition

Info

Publication number
JPS5262273A
JPS5262273A JP51139026A JP13902676A JPS5262273A JP S5262273 A JPS5262273 A JP S5262273A JP 51139026 A JP51139026 A JP 51139026A JP 13902676 A JP13902676 A JP 13902676A JP S5262273 A JPS5262273 A JP S5262273A
Authority
JP
Japan
Prior art keywords
ppoduction
benzisothiazolone
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51139026A
Other languages
English (en)
Inventor
Hawaado Batsugiyarii Keisu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of JPS5262273A publication Critical patent/JPS5262273A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP51139026A 1975-11-18 1976-11-18 Ppoduction of benzisothiazolone and pharmaceutical composition Pending JPS5262273A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4737375 1975-11-18

Publications (1)

Publication Number Publication Date
JPS5262273A true JPS5262273A (en) 1977-05-23

Family

ID=10444739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51139026A Pending JPS5262273A (en) 1975-11-18 1976-11-18 Ppoduction of benzisothiazolone and pharmaceutical composition

Country Status (28)

Country Link
US (5) US4113728A (ja)
JP (1) JPS5262273A (ja)
AR (3) AR217411A1 (ja)
AT (1) AT355017B (ja)
AU (2) AU504599B2 (ja)
BE (1) BE848371A (ja)
BG (4) BG24808A3 (ja)
CA (1) CA1064511A (ja)
CH (1) CH627465A5 (ja)
CS (4) CS192592B2 (ja)
DD (1) DD127645A5 (ja)
DE (1) DE2652201A1 (ja)
DK (1) DK517776A (ja)
ES (3) ES453420A1 (ja)
FI (1) FI763285A (ja)
FR (1) FR2332019A1 (ja)
HU (1) HU173958B (ja)
IL (1) IL50690A (ja)
NL (1) NL7612796A (ja)
NO (1) NO763922L (ja)
NZ (1) NZ182325A (ja)
PH (1) PH13918A (ja)
PL (1) PL193742A1 (ja)
PT (1) PT65851B (ja)
RO (4) RO75540A (ja)
SE (1) SE7612919L (ja)
SU (4) SU682129A3 (ja)
ZA (1) ZA766489B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ182325A (en) * 1975-11-18 1979-03-16 Beecham Group Ltd 2-substituted-1,2-benzisothiazol-3-ones
US4190663A (en) * 1976-01-24 1980-02-26 Bayer Aktiengesellschaft Anti-thrombotic 1,2-benzisothiazolin-3-ones
DE2602643C2 (de) * 1976-01-24 1984-12-20 Bayer Ag, 5090 Leverkusen 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
DE2860750D1 (en) * 1977-06-20 1981-09-17 Beecham Group Plc Antithrombotic 2-(gamma-(1-piperidinyl)propyl)1,2-benzisothiazol 3-one, its pharmaceutically acceptable acid addition salts, their preparation and their compositions
EP0001503B1 (en) * 1977-10-08 1981-01-07 Beecham Group Plc Antithrombotic compositions containing benzisothiazolones
EP0026791B1 (en) * 1979-10-08 1984-05-02 Merck & Co. Inc. 2-aryl-1,2-benzisothiazolinone-1,1-dioxides and pharmaceutical compositions containing them
DE3226284A1 (de) * 1982-07-14 1984-01-19 A. Nattermann & Cie GmbH, 5000 Köln Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3238006A1 (de) * 1982-10-13 1984-04-19 Bayer Ag, 5090 Leverkusen Azolyl-methylamine, ihre herstellung und verwendung in mikrobiziden mitteln
DE3500577A1 (de) * 1985-01-10 1986-07-10 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 1,2-benzisothiazolonen
US4732984A (en) * 1985-10-17 1988-03-22 American Home Products Corporation Piperazinoisothiazolones with psychotropic activity
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
CA1340759C (en) * 1988-07-01 1999-09-21 James P. Albarella Isobenzothiazolone chromogenic thiol indicators and their derivatives
US5128457A (en) * 1988-07-01 1992-07-07 Miles Inc. Chromogenic thiol indicators based on an isobenzothiazolone ring system
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
EP2344479B1 (en) * 2008-09-23 2015-04-08 Georgetown University 1,2-benzisothiazolinone and isoindolinone derivatives
WO2013025897A1 (en) 2011-08-16 2013-02-21 Georgetown University Methods of treating bacterial infections with 1,2-benzisothiazolinone and isoindolinone derivatives
US20180318818A1 (en) 2015-10-19 2018-11-08 Emory University Redox Dehydration Coupling Catalysts and Methods Related Thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE565380A (ja) * 1957-03-08
US3012039A (en) * 1958-03-14 1961-12-05 Ici Ltd 2-p-chlorobenzyl-1, 2-benzisothiazolone
DE1147947B (de) * 1961-07-25 1963-05-02 Knoll Ag Verfahren zur Herstellung neuer 1, 2-Benzisothiazolone
SE392103B (sv) * 1970-04-27 1977-03-14 Sherwin Williams Co Sett att framstella 1,2-bensisotiazolin-3-oner
US3661974A (en) * 1970-04-27 1972-05-09 Sherwin Williams Co 2-carbalkoxy-phenyl sulfenamides
NZ182325A (en) * 1975-11-18 1979-03-16 Beecham Group Ltd 2-substituted-1,2-benzisothiazol-3-ones
GB1582214A (en) * 1977-05-31 1981-01-07 Beecham Group Ltd Antithrombotic compositions
DE2734882A1 (de) * 1977-08-03 1979-02-22 Basf Ag 3- eckige klammer auf 4-(1,3-diazacycloalken-2-yl)-phenyl eckige klammer zu -1,2-benzisothiazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
PT65851B (en) 1978-05-15
CS192592B2 (en) 1979-08-31
FI763285A (ja) 1977-05-19
NZ182325A (en) 1979-03-16
AU4716379A (en) 1979-09-27
FR2332019B1 (ja) 1983-05-20
AT355017B (de) 1980-02-11
AR215271A1 (es) 1979-09-28
IL50690A (en) 1980-01-31
US4212872A (en) 1980-07-15
AU504599B2 (en) 1979-10-18
RO75777A (ro) 1981-02-28
PH13918A (en) 1980-11-04
ES453420A1 (es) 1978-02-16
FR2332019A1 (fr) 1977-06-17
CS192570B2 (en) 1979-08-31
ES465174A1 (es) 1978-10-01
IL50690A0 (en) 1976-12-31
US4350702A (en) 1982-09-21
PT65851A (en) 1976-12-01
AR217449A1 (es) 1980-03-31
CS192594B2 (en) 1979-08-31
US4243669A (en) 1981-01-06
SU679141A3 (ru) 1979-08-05
ES465173A1 (es) 1978-10-01
AU1916376A (en) 1978-05-04
HU173958B (hu) 1979-09-28
RO75730A (ro) 1981-02-28
SU682129A3 (ru) 1979-08-25
ATA849176A (de) 1979-07-15
AU520890B2 (en) 1982-03-04
BG24808A3 (en) 1978-05-12
US4113728A (en) 1978-09-12
BG24809A3 (en) 1978-05-12
SU701536A3 (ru) 1979-11-30
BE848371A (fr) 1977-05-16
US4212979A (en) 1980-07-15
DE2652201A1 (de) 1977-06-02
CS192593B2 (en) 1979-08-31
DD127645A5 (ja) 1977-10-05
BG24810A3 (en) 1978-05-12
BG24811A3 (en) 1978-05-12
SE7612919L (sv) 1977-05-19
AR217411A1 (es) 1980-03-31
DK517776A (da) 1977-05-19
CA1064511A (en) 1979-10-16
ZA766489B (en) 1977-10-26
NL7612796A (nl) 1977-05-23
SU671728A3 (ru) 1979-06-30
CH627465A5 (de) 1982-01-15
PL193742A1 (pl) 1979-05-21
NO763922L (ja) 1977-05-20
RO69608A (ro) 1982-07-06
RO75540A (ro) 1980-11-30

Similar Documents

Publication Publication Date Title
NZ181444A (en) -phenyl benzylidene derivatives and pharmaceutical compositions
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
IL50815A0 (en) New aminobenzoamides their preparation and pharmaceutical compositions containing them
JPS5262273A (en) Ppoduction of benzisothiazolone and pharmaceutical composition
GB1520447A (en) Benzisoquinoline derivatives and pharmaceutical uses thereof
ZA763917B (en) Pharmaceutical compositions and compounds
JPS5262263A (en) Esteranic steroid and pharmaceutical composition thereof
PH15711A (en) Acylamino derivatives and pharmaceutical compositions thereof
IL50631A (en) 1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
NZ180379A (en) Benzophenone derivatives and pharmaceutical composition
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
PH13912A (en) Substituted benzamide derivatives and pharmaceutical compositions thereof
NZ181168A (en) 3-sulphamyl benzylamine derivatives and pharmaceutical compositions intermidiates
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
NZ181401A (en) 2-benzopyranone derivatives and pharmaceutical compositions
JPS5223010A (en) Preparation and use of 1*11 dichlorr44methyll33hydroxyy bentt11en
JPS51144720A (en) Stable medical composition and its preparation of ergotalkaloids
JPS527419A (en) Heterocolloidal deblicin containing medical composition and its preparation
NZ181146A (en) Benzocycloheptathiophene derivatives and pharmaceutical compositions
NZ185318A (en) Derivatives of 1-phenoxy-3-amino-2-propanol and pharmaceutical compositions